| abstract |
A compound that is useful as a GK activator is described. Studies have been done with respect to compounds that have an activation action of GK and, therefore, are favorable as active ingredients of pharmaceutical compositions for the treatment of diabetes, type 2 diabetes, obesity, metabolic syndrome and diseases associated with the aforementioned conditions, and it is confirmed that a specific benzamide compound has an excellent GK activation action. The benzamide compound has a GK activation action and can be used as a prophylactic and / or therapeutic agent for diabetes, type 2 diabetes, obesity, metabolic syndrome and diseases associated with the aforementioned conditions. |